Health ❯Healthcare ❯Pharmaceuticals

Vaccine Development

mRNA Vaccines COVID-19 Vaccines COVID-19 Vaccine Updated COVID-19 Vaccines Protein-based Vaccines Pfizer RSV Vaccine Clinical Trials New Vaccines Covid-19 Vaccines Competitive Landscape Clinical Approvals Amgen Regulatory Oversight Biontech and Pfizer Moderna and Pfizer Vaccines Legal Issues in Vaccination Emergency Use Authorization mRNA Technology

Moderna Reports Larger-Than-Expected Q4 Loss as COVID Vaccine Sales Plummet

BioNTech Settles COVID-19 Vaccine Royalty Disputes for $1.2 Billion

BioNTech and Pfizer Agree to $1.2 Billion Settlement Over U.S. Vaccine Patent Disputes

FDA Official Warns of Vaccine Challenges Under Trump Administration

Canada Approves Moderna's mRNA RSV Vaccine for Seniors

Moderna Reports Unexpected Profit on Strong COVID Vaccine Sales

Biontech's Revenue Surges with Updated Covid-19 Vaccine

CDC Approves Expanded Vaccine Recommendations for Older and Immunocompromised Individuals

FDA Halts Novavax's COVID-Flu Combo Vaccine Trial Over Safety Concerns

Ontario, Quebec, Nunavut to Offer Universal RSV Protection for Infants

Health Canada Approves Pfizer's Updated COVID-19 Vaccine

Health Canada Approves Updated Novavax COVID-19 Vaccine for Fall

Health Canada Approves Moderna's Updated COVID-19 Vaccine

New COVID-19 and Flu Vaccines Approved and Rolling Out Nationwide

FDA Approves Updated COVID-19 Vaccines Targeting New Variants